Mannon P, Reinisch W. 2012. Interleukin 13 and its role in gut defence and inflammation. Gut. 61(12):1765-73. PMID: 22942239
Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature. 486(7402):215-21. PMID:22699610
Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207-14. PMID:22699609
Segata N, Haake SK, Mannon P, Lemon KP, Waldron L, Gevers D, Huttenhower C, Izard J. 2012. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13(6):R42. PMID:22698087
Schepp-Berglind J, Atkinson C, Elvington M, Qiao F, Mannon P, Tomlinson S. 2012. Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis. J Immunol. 188(12):6309-18. PMID:22566568
Mannon PJ. 2011. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease. Expert Opin Biol Ther. (9):1249-56. PMID:21787241
Imamichi H, Degray G, Dewar RL, Mannon P, Yao M, Chairez C, Sereti I, Kovacs JA. 2011. Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. J Infect Dis. 204(2):309-14. PMID:21673043
Read SW, Ciccone EJ, Mannon PJ, Yao MD, Chairez CL, Davey RT, Kovacs JA, Sereti I. 2011. The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients. J Acquir Immune Defic Syndr. 56(4):340-3. PMID:21350367
Mannon PJ. 2011. Environmental triggers, genetic background, and Crohn's disease. Gastroenterology. 140(1):363-5. PMID:21094202
Mannon PJ, Hornung RL, Yang Z, Yi C, Groden C, Friend J, Yao M, Strober W, Fuss IJ. 2011.
Suppression of inflammation in ulcerative colitis by interferon-{beta}-1a is accompanied by inhibition of IL-13 production. Gut. 60(4):449-55 PMID: 20971977 PMCID:PMC3430969
Mannon P. 2009. Gut permeability and colitis. Gastroenterology. 137(2):732-4 PMID: 19567237
Mannon, PJ. 2008. A common barrier defect for celiac disease and ulcerative colitis. Gastroenterology. 135(6):2145-7 PMID: 19013169
Mannon, P. 2007. GAIN for loss: adalimumab for infliximab-refractory Crohn disease.
Ann Intern Med.146(12):888-90 PMID: 17577009
Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, Yang Z, Yi C, Quezado M, Brown M, Strober W. 2006. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 131(3):748-56 PMID: 16952544
Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Yang Z, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W; Anti-IL-12 Crohn’s Disease Study Group. 2004. Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med. 351(20):2069-79. Erratum in: N Engl J Med. 2005 Mar 24;352(12):1276 PMID: 15537905